Cargando…

Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients

OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA....

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mijalli, Samiah Hamad S, Shami, Ashwag Y, Al-Salem, Rasha A, Alnafisi, Nawaf M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SBDR - Society for Biomedical Diabetes Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044050/
https://www.ncbi.nlm.nih.gov/pubmed/35831935
http://dx.doi.org/10.1900/RDS.2022.18.135
_version_ 1784913278534680576
author Al-Mijalli, Samiah Hamad S
Shami, Ashwag Y
Al-Salem, Rasha A
Alnafisi, Nawaf M
author_facet Al-Mijalli, Samiah Hamad S
Shami, Ashwag Y
Al-Salem, Rasha A
Alnafisi, Nawaf M
author_sort Al-Mijalli, Samiah Hamad S
collection PubMed
description OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA. We cultured the urine specimens obtained from diabetic patients based on optimal aerobic and anaerobic microbiological methods. By adopting standard microbiological methods, we identified the bacterial isolates. We also followed the guidelines of the Clinical and Laborator y Standards Institute (CLSI) to do antibiotic susceptibility testing. RESULTS: A total of 100 isolates were evaluated, and a total of 22 organisms were isolated. The majority were multidrug-resistant organisms. Streptococcus haemolyticus was the most frequent organism and rated (15%). It was followed by Staphylococcus hominis (11%), Pseudomonas aeruginosa (9%), Enterococcus faecalis (9%), Enterococcus fiseum (7%), Escherichia coli (7%), Staphylococcus aureus (7%), Staphylococcus lantus (5%) and Klebsiella pneumoniae (5%). We also found multi-microbial infections. Most of the organisms were susceptible to tigecycline, gentamycin, and nitrofurantoin, rating (88%), (84%) and (78%), respectively. CONCLUSIONS: Our study revealed that a wide range of pathogens affects the diabetes patients. Staphylococcus haemolyticus is the most prevalent pathogen. We observed considerable antimicrobial resistance. Tigecycline had a wide sensitivity spectrum and was effective against most of the bacteria. Thus, it can be used as an empirical antibiotic.
format Online
Article
Text
id pubmed-10044050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SBDR - Society for Biomedical Diabetes Research
record_format MEDLINE/PubMed
spelling pubmed-100440502023-03-29 Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients Al-Mijalli, Samiah Hamad S Shami, Ashwag Y Al-Salem, Rasha A Alnafisi, Nawaf M Rev Diabet Stud Research OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA. We cultured the urine specimens obtained from diabetic patients based on optimal aerobic and anaerobic microbiological methods. By adopting standard microbiological methods, we identified the bacterial isolates. We also followed the guidelines of the Clinical and Laborator y Standards Institute (CLSI) to do antibiotic susceptibility testing. RESULTS: A total of 100 isolates were evaluated, and a total of 22 organisms were isolated. The majority were multidrug-resistant organisms. Streptococcus haemolyticus was the most frequent organism and rated (15%). It was followed by Staphylococcus hominis (11%), Pseudomonas aeruginosa (9%), Enterococcus faecalis (9%), Enterococcus fiseum (7%), Escherichia coli (7%), Staphylococcus aureus (7%), Staphylococcus lantus (5%) and Klebsiella pneumoniae (5%). We also found multi-microbial infections. Most of the organisms were susceptible to tigecycline, gentamycin, and nitrofurantoin, rating (88%), (84%) and (78%), respectively. CONCLUSIONS: Our study revealed that a wide range of pathogens affects the diabetes patients. Staphylococcus haemolyticus is the most prevalent pathogen. We observed considerable antimicrobial resistance. Tigecycline had a wide sensitivity spectrum and was effective against most of the bacteria. Thus, it can be used as an empirical antibiotic. SBDR - Society for Biomedical Diabetes Research 2022-06-30 /pmc/articles/PMC10044050/ /pubmed/35831935 http://dx.doi.org/10.1900/RDS.2022.18.135 Text en Copyright © by Lab & Life Press https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 Unported (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Research
Al-Mijalli, Samiah Hamad S
Shami, Ashwag Y
Al-Salem, Rasha A
Alnafisi, Nawaf M
Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title_full Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title_fullStr Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title_full_unstemmed Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title_short Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
title_sort development of diagnostic capabilities for complications of bacterial infection in diabetic patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044050/
https://www.ncbi.nlm.nih.gov/pubmed/35831935
http://dx.doi.org/10.1900/RDS.2022.18.135
work_keys_str_mv AT almijallisamiahhamads developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients
AT shamiashwagy developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients
AT alsalemrashaa developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients
AT alnafisinawafm developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients